LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is delighted to announce that it has ...
London, UK & Boston, MA, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the ...
Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the orphan ...
London, UK and Boston, MA – 15th August 2023: Global pharmaceutical revenues are forecast to grow at a compounded annual rate of 5.9% to 2028, with global prescription drug sales predicted to be worth ...
Both companies are now under the Norstella umbrella. Evaluate announced the acquisition of J+D Forecasting, a provider of forecasting solutions focused on the pharmaceutical and life sciences industry ...
LONDON – [7 January 2026] – Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2026 Preview report, providing market forecasts for biopharma in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results